Neurologicall Pharmacology Flashcards
What is IPD?
Idiopathic PArkinsons disease:
• Neurodegenerative disorder - don’t know why the neurones degenerate
• Progressive clinical course - not symmetrical, one sided
• Motor symptoms improve with levodopa
• Non motor symptoms
What are the clinicl features of parkinsonism
- Tremor* - Pill rolling tremour , very small amplitude
- Rigidity* -
- cog wheel rigidity - when patients move wrist through arc, can feel cog wheeling
- lead pipe rigidity = same thoughout bend. Can have resistance, then give
• Bradykinesia** Caused by low dopamine state.
Degeration of opamine neurones
in substantia nigra low dopamine
in particular causes bradykinesia
• Postural instability
*low dopamine and disturbance
other neurotransmitter levels
**low dopamine
What are non-motor manifestations of parkinsonism
- Mood changes
- Pain
- Cognitive change - dementia
- Urinary symptoms
- Sleep disorder - rem sleep behavious disorder
- Sweating,e xcessive drooling
Describe the prognosis in PD
• 94% Dyskinesia - involuntary writhing movements caused by l-dopa
• 81% Falls - not a feature of early parkinsons
• 84% Cognitive decline (50%
hallucinations) - due to synuclein deposits which damage cells
• 80% Somnolence - exacerbated by drugs
• 50% Swallowing difficulty - a lot of drugs are oral
• 27% Severe speech problems - very very low volume
How can IPD be diagnosed
- Clinical Features
- Exclude other causes of Parkinsonism
- Response to Treatment
- Structural neuro imaging is normal
What are other causes of parkinsonism
- Drug induced PArkinsonism
- Vascular parkinsonism
- Progressive supranuclear palsy
- Multiple systems atrophy
- Corticobasal degeneration
What is a DAT scan?
- Labelled tracer
- Presynaptic uptake
- Abnormal in PD
- Not diagnostic
- Tremor
- Neuroleptic
- Vascular
Labelling ability to reuptake dopamine. Asymmetrical ii Parkinson’s . This isnt a scan
for Parkinson’s. Any conditions that damages the basal ganglia, will have abnormal
scan. These scans - if someone has a tremor - we do the scan - if it’s normal - a
tremor but for reasons that aren’t Parkinson’s if the skkan is normal. Euroleptic
drugs - tip someone to a tendency for Parkinson’s or might cause extrapyramidal
side effects. If your not sure in someone taking these drugs - ifi it’s normal, its the
drugs. If its not normal - combination of both
Describe the pathology of IPD
• Neurodegeneration • Lewy bodies – synucleinopathy • Loss of pigment – 50% loss->symptoms – Increased turnover – Upregulate receptors • Reduced dopamine
Cell bodied in substantiaa nigra - dopamnergic cells.. n PID those cells disappeared. Motor symptoms dont manifest until 50% lost. Already lost half the neurones. Need to predict so they can be treated before
Describe catecholamine synthesis
ss
Describe dopamine degradation
ss
What are drug classes used in IPD?
- Levodopa (L-DOPA)
- Dopamine receptor agonists
- MAOI type B inhibitors
- COMT inhibitors
- Anticholinergics
- Amantidine
Why is dopamine not used in IPD treatment?
does nto cross the bbb
What is L-dopa?
Levodopa must be taken up by dopaminergic cells in the substantia nigra
to be converted to dopamine. Fewer remaining cells - less reliable effect
of levodopa- motor fluctuations
Describe the PK of l-dopa
- Oral administration
- Absorbed by active transport • In competition with amino acids (NB high protein meals)
- 90% inactivated in intestinal wall • monoamine oxidase & DOPA decarboxylase
- T1/2 2 hours
• short dose interval
• fluctuations in blood levels and symptoms
• (physiologically dopamine is produced tonically)
• 9% converted to dopamine in peripheral tissues
• DOPA decarboxylase
• <1% enters CNS
• Again competes with amino acids for active transport across blood brain
barrier
What is l-dopa used in combination with and why
L-DOPA is used in combination with a peripheral DOPA decarboxylase inhibitor : • Co-careldopa - Sinemet • Co-beneldopa - Madopar • Reduced dose required • Reduced side effects • Increased L-DOPA reaching brain
How do peripheral dopa decarbocylase inhibitors work?
Inhibit peripheral dopa decarboxylase, less l-dopa metabolised